Abstract-The basal expression patterns of NO synthase (NOS; endothelial [eNOS], neuronal [nNOS], and cytokineinducible [iNOS]) and superoxide dismutase (SOD; extracellular membrane bound [ECSOD], MnSOD, and CuZnSOD) isoforms in ferret heart (tissue sections and isolated myocytes) were determined by immunofluorescent localization. We demonstrate the following for the first time in the mammalian heart: (1) heterogeneous expression patterns of the 3 NOS and 3 SOD isoforms among different tissue and myocyte types; (2) colocalization of eNOS and ECSOD at both the tissue and myocyte levels; (3) a significant gradient of eNOS and ECSOD expression across the left ventricular (LV) wall, with both enzymes being highly expressed and colocalized in LV epicardial myocytes but markedly reduced in LV endocardial myocytes; and (4) specific subcellular localization patterns of eNOS and the 3 SOD isoforms. In particular, eNOS and ECSOD are demonstrated (electron and confocal microscopy) to be specifically localized to the sarcolemma of ventricular myocytes. Similar heterogeneous eNOS and ECSOD expression patterns were also obtained in human LV tissue sections, underscoring the general importance of these novel findings. Our data suggest a strong functional correlation between the activities of sarcolemmally localized myocyte eNOS and ECSOD in governing NO⅐/O 2 Ϫ interactions and suggest that NO-related modulatory effects on cardiac myocyte protein and/or ion channel function may be significantly more complex than is presently believed. (Circ Res. 1999;85:575-587.)
T he modulatory effects of nitrogen oxides on cardiac function have recently received extensive experimental attention. However, although there is general consensus that NO-related activity can exert significant chronotropic and inotropic effects on the heart, 1,2 both positive and negative effects have been reported. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Controversy also exists on the obligatory versus secondary involvement of NO-related activity on cardiac myocyte ion channel function. 8 -16 The following 2 interrelated issues may underlie the apparently conflicting results that have been reported: (1) NO synthase (NOS) protein expression patterns among different cardiac tissues and myocyte types have not been adequately analyzed, and (2) nearly all studies have equated "NO" to free radical nitric oxide, NO⅐, and have attributed all NO-related effects to the indirect NO⅐3soluble guanylyl cyclase3cyclic GMP cascade (reviewed in Reference 17) . In particular, although it has been established that the indirect NO⅐-cGMP pathway exists in many cardiac myocyte types, 1, 2, [7] [8] [9] [10] [11] 17 N-oxides can also exist in other physiologically relevant redox-related forms, including S-nitrosothiols (RSNOs) and peroxynitrite (OONO Ϫ , a potent oxidant). These 2 NO-related species display unique reactivity profiles with different target molecules 18 -22 and can potentially exert direct cGMP-independent effects through reactions involving (1) S-nitrosylation of single regulatory thiols (Equation 1) and/or (2) oxidation of vicinal thiols (Equation 2), as follows:
(1) RSNOϩRЈSH3 RЈSNO (S-nitrosylation, single regulatory thiols) (2) RSNO/OONO Ϫ ϩSHϩS Ϫ 
SϪS (oxidation, regulatory disulfide formation)
Evidence for direct NO-related modulation of various ion channel proteins has recently been reported, including aortic calcium-activated potassium channels, 23 neuronal NMDA receptors, 24 cardiac sarcoplasmic reticulum calcium release channels, 25 rabbit cloned cardiac L-type calcium channel ␣ 1C subunits, 26 and native L-type calcium channel complexes in ferret right ventricular myocytes. 7 A scenario therefore emerges wherein NO-related activity could modulate cardiac function by both indirect and direct mechanisms. 7,18 -21,26 However, the molecular mechanisms determining the predominance of these 2 pathways in cardiac myocytes are essentially unknown. Two mechanisms could be as follows:
(1) If NO/RSNOs are mainly produced by endogenous intracellular NOS activity in myocytes, the indirect effects of cGMP may dominate (eg, References 7-11); alternatively, if NO⅐/O 2 Ϫ or RSNOs are generated either at the sarcolemmal surface or from other extracellular (ie, nonmyocyte) sources, direct NO ϩ transfer (Equation 1) and/or oxidation (Equation 2) reactions may dominate (eg, References 7, [18] [19] [20] [21] 23, 24, 26) .
(2) OONO Ϫ forms from the rapid reaction (4 to 7ϫ10 9 /Msec) of NO⅐ with superoxide free radical, O 2 Ϫ . 18, 22, 27 O 2 Ϫ is generated under normal physiological conditions by numerous metabolic processes, including the activity of NOS isoforms and membrane-bound NADPH oxidases. 28, 29 O 2 Ϫ could serve as a primary "scavenger" of NO⅐ in extracellular and sarcolemmal domains, and as a result OONO Ϫ production could predominate when NO-and O 2 -related species are formed simultaneously in closely adjacent cellular domains. 19, 22, 27 Hence, the expression levels and specific localization patterns of superoxide dismutase (SOD) isoforms 30, 31 (see Materials and Methods) could be important factors in governing NO-related effects. For example, regulation of extracellular O 2 Ϫ levels by the extracellular/membrane-bound isoform 7, 27, 30, 31 (ECSOD) could facilitate indirect effects; in contrast, in tissue regions where ECSOD is reduced or absent, direct NO-related effects could potentially dominate.
Although endothelial NOS (eNOS), [32] [33] [34] [35] [36] cytokineinducible NOS (iNOS), 33, 37, 38 and neuronal NOS (nNOS) 39 expression in cardiac muscle have all been reported, it has not been determined whether NOS isoform expression levels are uniform or heterogeneous among different cardiac tissue and myocyte types. Furthermore, essentially no data exist on expression patterns of SOD isoforms 27, 30, 31 in cardiac tissue. To begin to address these important issues, we have conducted immunolocalization studies on the basal expression levels of NOS and SOD isoforms in ferret and human heart tissue sections and ferret enzymatically isolated cardiac myocytes. We concentrated on the following 2 basic questions: (1) Are basal NOS and SOD isoform expression patterns uniform or heterogeneous in the heart? (2) Are the expression patterns of NOS and SOD isoforms, and in particular eNOS and ECSOD, appropriate to suggest a functional correlation between the activities of these 2 enzyme systems 7, 27 in NO-related modulation of cardiac myocyte protein and ion channel function 7, 19, [23] [24] [25] [26] [27] ?
Materials and Methods

Terminology and Abbreviations
Three isoforms of NOS have been described in mammalian cells: nNOS (type I), iNOS (type II), and eNOS (type III). 33 eNOS has been proposed to be associated with cell membrane caveolae, 32 whereas nNOS and iNOS are assumed to be cytosolic 33, 39 (however, see Reference 40) . The following 3 isoforms of SOD have also been described in mammalian cells: MnSOD, localized to the mitochondrial matrix; CuZnSOD, diffusely spread throughout the cytoplasm; and ECSOD, distributed on cell membranes and in extracellular fluids because of the presence of a heparin binding domain. 27, 30, 31 We have retained this terminology. For ease of presentation, the following abbreviations are used: SAN, sinoatrial node; RA, right atrium; RV, right ventricle; LV, left ventricle; and LV epi and LV endo, left ventricular epicardium and endocardium, respectively. The following terms have also been used: (1) "whole free wall" refers to a preparation obtained from the entire wall of a specific anatomic region (RA, RV, or LV), in contrast to "LV epi" and "LV endo," which refer to preparations obtained specifically from the LV epicardial and endocardial surfaces; (2) "indirect IF" refers to immunofluorescence (IF) obtained using unconjugated primary antibody and fluorochrome-conjugated secondary antibody; and (3) "direct IF" refers to results obtained by direct binding of fluorochrome-conjugated primary antibody in situ. 41, 42 This investigation conforms with the guidelines for the use and care of laboratory animals as outlined by the National Institutes of Health (NIH publication 8523).
Light Microscopy and Immunolocalization
Isolated Myocytes
Myocytes were enzymatically isolated from specific anatomic regions (SAN, RA, RV [entire free wall], and approximately the middle one third of the LV epi and LV endo surfaces) of the hearts of healthy adult male ferrets (anesthetized via 35 mg/kg pentobarbital, IP) using an enzyme perfusion solution (collagenase, elastase, and protease; Langendorff apparatus) and subsequent enzyme treatment of dissected tissue samples as previously described. 7, 42 After isolation, myocytes were washed twice in PBS (in mmol/L: NaCl 128, KCl 2, Na 2 HPO 4 8, and KH 2 PO 4 2, pH 7.2) and then fixed as previously described. 41, 42 Primary antibodies and respective dilutions used in this study were the following: (1) NOS antibodies (anti-human mouse monoclonal antibodies [Transduction Laboratories]), dilution 1:2500, and (2) SOD antibodies (antihuman rabbit polyclonal antibodies [kindly provided by Drs James Crapo and Tim Oury, Duke University]), which were ECSOD, dilution 1:2200; MnSOD, dilution 1:2600; and CuZnSOD, dilution 1:3000. Antimouse IgG conjugated with TRITC and anti-rabbit IgG conjugated with FITC (The Jackson Laboratories) were used as secondary antibodies. For direct IF, primary antibodies were conjugated with either TRITC (for NOS) or FITC (for SOD). For positive controls, cardiac-specific troponin antibody (troponin C-FITC, Novacastra Laboratories, Ltd) was used. For NOS-negative controls, myocytes were incubated with blocking buffer, whereas for ECSOD-negative controls myocytes were incubated with 100 units of heparin (1 hour, room temperature) before fixation. Slides were scanned using a Zeiss LSM410 confocal microscope. Digitized images were subsequently processed as previously described. 41, 42 Approximate percentage expression levels of different isoforms among myocyte samples ( Figure 5 ) were estimated by visual examination and enumeration as previously described. 41, 42 Tissue Sections
Ferret Heart
After Langendorff perfusion with PBS, whole hearts were fixed as previously described. 41, 42 Tissue section localizations were performed on hearts from 4 to 7 ferrets for each isoform analyzed. For each individual heart, a total of 40 to 50 cryosections were made of a specific anatomic region (RA, entire ventricle), and every ninth section was sampled and analyzed. For the ventricular sections (7 m thickness; cut orientation as indicated in Figure 2A ), the following numbers of measurements were performed for each isoform: eNOS and ECSOD, 7 hearts, 5 sections per heart; nNOS, 5 hearts, 4 sections per heart; iNOS, 4 hearts, 4 sections per heart; and MnSOD and CuZnSOD, 6 hearts, 4 sections per heart. eNOS and ECSOD localization in transverse cryosections of RA (6 m thickness; cut orientation through the superior vena caval and sinoatrial nodal regions as shown in Figure 3A2 ) were conducted on 4 hearts, with 4 sections per heart. RA and sagittal ventricular cryosections were postfixed 41, 42 before immunofluorescent localization was performed.
Human LV
LV epi and LV endo tissue sections were prepared from 3 hearts obtained after rapid autopsy (samples kindly provided by Dr J.S. Reimer, Department of Pathology and Alzheimers Research Study Group, Duke University). Cryosections (nϭ40 to 50) were prepared from the indicated LV epi and LV endo regions shown in Figure 4A2 (white boxes). Every 7th section (a total of 5 sections per heart) was sampled and analyzed for eNOS and ECSOD expression. Tissue sections were obtained from the hearts of white males 32, 48, and 67 years of age, none of whom had any reported clinical history of heart disease. Cryosections were rapidly fixed (3% paraformaldehyde/1% glutaraldehyde) and subsequently prepared and analyzed using eNOS and ECSOD antibodies as described above for ferret heart.
Electron Microscopy (EM)
For EM analysis of SOD isoforms in ferret LV epi and LV endo tissue sections (Figure 6 ), standard double immunolabeling techniques were applied. [43] [44] [45] Ultrathin (60 nm) cryosections were blocked with preimmune serum followed by primary antibody incubation. Binding patterns were determined by application of protein A gold (PAG; CuZnSOD, 5-nm particles; MnSOD, 10-nm particles; and ECSOD, 15-nm particles). Sections were then analyzed using a Philips CM-10 electron microscope.
Antibody Characterization
Membrane Preparations
Ferret hearts were rinsed in PBS at room temperature and then frozen at -70°C. Both ferret heart and various standard membrane preparations (see below) were prepared as previously described, 46 with the following modifications (all procedures conducted at 4°C). Solutions contained the following mixture of protease inhibitors: aprotinin 2 mg/mL; benzamide 0.5 mmol/L; iodoacetamide 0.6 mmol/L; leupeptin 0.15 mol/L; pefabloc 0.5 mmol/L; pepstatin 1 mol/L; and 1,10 phenanthroline 0.5 mmol/L. Specific tissue samples were suspended in TE buffer (10 mmol/L TRIS and 1 mmol/L EDTA), homogenized, centrifuged (1000g, 10 minutes), and the supernatant was collected and recentrifuged (60 000g, 30 minutes). The pellet was then resuspended in TE buffer with 0.6 mol/L KI, incubated on ice for 15 minutes, centrifuged (60 000g, 30 minutes), and washed twice with TE buffer to remove KI. The pellet was solubilized in 2% Triton ϫ100 -TE buffer on ice for 1 hour and then centrifuged at 15 000g for 15 minutes. Protein content was determined using a BCA protein assay.
Immunoblot Analysis
Membrane and tissue homogenates were resolved on 7.5% or 10% SDS-PAGE gels (Prosieve 50 solution, FMC) with appropriate protein markers, followed by transfer to ECL Hybond nitrocellulose membrane (Amersham). After incubation with 1% BSA in PBS-0.05% Tween 20 (blocking buffer), the blots were incubated in appropriate antibody diluted in blocking buffer (dilutions were the following: eNOS, nNOS, and iNOS, 1:2500; ECSOD, 1:2500; MnSOD, 1:2600; and CuZnSOD, 1:3000) for 1 hour, washed 3 times with PBS-Tween 20, and subsequently incubated in horseradish peroxidase-conjugated secondary antibody. The blots were washed 5 times and visualized by enhanced chemiluminescence (Amersham). Relative band intensities were compared by use of NIH Image, IP Laboratory Gel, and Image Quant software. For each antibody, a specific "positive control" was used, for which that antibody reacted at a maximal level, and the band intensities obtained from these positive controls were defined as 100%. The density of each preparation was then percentage-normalized relative to the appropriate 100% positive control. Positive controls were as follows: eNOS, human endothelial cells (En); nNOS, rat pituitary cells (Pi); iNOS, mouse macrophages (Ma); ECSOD and MnSOD, human lung cells (HL); and CuZnSOD, human red blood cells. We wish to emphasize that the relative percentage band intensities reported ( Figure 1 ) are given only for comparative purposes for each individual antibody and are not for comparative purposes between different antibodies.
Interpretive Limitations
In interpreting our IF results, we wish to emphasize the following 2 points. (1) For numerous reasons (eg, monoclonal versus polyclonal antibodies, possible differences in number, accessibility, and/or affinity of epitopes, etc), the fluorescent intensities obtained for any one specific NOS or SOD isoform cannot be quantitatively compared with those obtained from another isoform; ie, only relative and/or qualitative comparisons among different isoforms are valid. Therefore, for comparative purposes, the relative intensity profiles 42 3 , and 4), NOS and/or SOD isoforms may not be expressed only in myocytes but also within other nonmyocyte cell types, eg, endothelial cells, smooth muscle cells, and neurons. Therefore, both the overall IF patterns and relative intensity profiles obtained from the ventricular and RA tissue sections cannot at present be attributed exclusively to NOS and SOD isoform expression within myocytes.
Results
Antibody Specificity: Immunoblot Analysis
Representative immunoblot results on the specificity of the antibodies used are shown in Figure 1 . Results were obtained 
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Heterogeneous NOS and SOD Expression in Heart , and G1 through G4, ϫ60 enlargements taken from the indicated (white boxes) apical and midventricular LV epi and LV endo regions in panels E, F, and G, respectively. Calibration bars: E1 and E3ϭ10 m. Subpanels E5 through E7, F5 through F7, and G5 through G7, Relative intensity profiles for eNOS and ECSOD measured at the indicated basal (5), midventricular (6) , and apical regions (7) (cyan transverse lines) for the corresponding sagittal sections in panels E, F, and G, respectively. Relative intensities were normalized by defining 0% as minimal fluorescence measured in negative controls (eg, panel C), and 100% as maximum fluorescence measured for each specific antibody at the 3 indicated cyan lines (see Material and Methods: Interpretive Limitations).
from protein homogenates prepared from specific regions of ferret heart (RV and LV whole free walls, LV epi, and LV endo) and brain (Br) and various positive control tissue preparations (eNOS, human En; nNOS, rat Pi; iNOS, mouse Ma; ECSOD and MnSOD, HL; and CuZnSOD, human red blood cells [RBC] ; see Materials and Methods: Immunoblot Analysis). Band intensities were expressed as percentage intensity relative to indicated specific positive controls. All 3 NOS antibodies displayed prominent single binding bands in both the various positive controls and ferret heart preparations. Among the heart preparations, eNOS (Ϸ140 kDa) was prominent in RV (relative band intensity, 82% of En) and LV (whole free wall, 81% of En); however, when LV epi and LV endo preparations were tested separately, eNOS in LV endo was markedly reduced (17% of En) compared with that in LV epi (69% of En). Both nNOS (Ϸ150 to 160 kDa) and iNOS (Ϸ130 kDa) could also be detected at low basal levels in both RV (nNOS, 21% of Pi; iNOS, 9% of Ma) and LV (nNOS, 16% of Pi; iNOS, 7% of Ma). Among the SOD antibodies, in general multiple binding patterns were observed in all preparations analyzed (MnSOD prominent at Ϸ22 kDa, CuZn-SOD at Ϸ25 and Ϸ29 kDa, ECSOD prominent at Ϸ33 kDa and more weakly at Ϸ29 kDa). These SOD antibody binding results are consistent with the known (but presently incompletely characterized) multimeric structure of SOD isoforms in other noncardiac cell types. 27, 30, 31 The SOD band patterns were also very similar among the various positive control and ferret cardiac preparations. However, when LV epi and LV endo preparations were tested separately, the prominent band for ECSOD binding (Ϸ33 kDa) was markedly reduced in LV endo (relative intensity of 23% of HL) compared with LV epi (63% of HL). Similar immunoblot results were consistently obtained from a total of 4 whole LV preparations and 6 LV epi and 6 LV endo preparations (each preparation made from a different heart).
Ferret Heart: NOS and SOD Isoform Protein Expression Patterns in Tissue Sections
Our immunoblot results ( Figure 1 ) suggested that there may be differences in expression levels of NOS and SOD isoforms in different regions of the heart, particularly across the LV wall. Therefore, we next determined overall expression patterns of NOS and SOD isoforms in ferret heart tissue sections. We particularly concentrated on eNOS and ECSOD because of the roles that these 2 enzymes could play in indirect versus direct extracellular/sarcolemmal NO-related effects. 7, 19, 27 eNOS and ECSOD: Ventricular and Right Atrial Tissue Sections Figure 2 shows IF results obtained on eNOS and ECSOD expression patterns in adjacent sagittal sections (7 m thick) of the ferret ventricle (see Figure 2A and 2B for section orientation). To verify secondary antibody specificity, a series of positive and negative control measurements were initially conducted. Binding of cardiac-specific troponin antibody (positive control) gave a high fluorescence signal that was uniform across all ventricular regions ( Figure 2B ). In contrast, in the absence of primary eNOS antibody ( Figure  2C ) and heparin-exposed sections treated with primary ECSOD antibody ( Figure 2D ), application of secondary antibodies (negative controls) failed to produce any significant fluorescence.
In marked contrast to troponin, binding of both eNOS ( Figure 2E , main panel, red fluorescence) and ECSOD ( Figure 2F , main panel, green) antibodies gave rise to distinct and heterogeneous basal expression patterns among different regions of the ventricle. Both eNOS and ECSOD expression levels were relatively high and uniform across the entire free wall of the RV, high in the apical and midventricular regions of the LV epi, and markedly reduced or absent in the LV endo and the LV side of the septum. This heterogeneous expression pattern is further emphasized in Figure 2E1 through 2E4 and 2F1 through 2F4, which show ϫ60 enlargements of the tissue regions indicated by the white boxes.
Comparison of the adjacent sections shown in Figure 2E and 2F suggested that there may also be a marked colocalization of eNOS and ECSOD expression in intact ventricular tissue. To verify colocalization, direct IF measurements (see Materials and Methods) were conducted on single sagittal sections treated with both eNOS and ECSOD antibodies. As shown in Figure 2G , both eNOS and ECSOD expression were found to be highly colocalized (ie, yellow-orange). To further demonstrate heterogeneous expression and colocalization, the relative fluorescence intensity profiles 42 of eNOS and ECSOD were measured transversely at the indicated apical, midventricular, and basal regions (cyan lines 5, 6, and 7 in Figure 2E and 2F). Although at present we do not wish to impart any further quantitative interpretation of these data (see Materials and Methods: Interpretive Limitations), it is nonetheless clear that there was a striking similarity between the relative intensity profiles of eNOS ( Figure 2E5 through 2E7) and ECSOD ( Figure 2F5 through 2F7) among corresponding transverse regions of the 2 adjacent sections. This is further emphasized in Figure 2G5 through 2G7, which overlay the relative eNOS and ECSOD intensity profiles for comparative purposes. In summary, heterogeneous eNOS and ECSOD expression and colocalization patterns similar to those shown in Figure 2 were consistently observed in ventricular sagittal sections prepared from a total of 7 ferret hearts.
Representative eNOS and ECSOD expression patterns in ferret right atrial tissue sections (6 m thick) are shown in Figure 3A through 3D (see figure legend for details). In contrast to the ventricle, both eNOS and ECSOD were uniformly expressed (Figure 3B and 3C ; indirect IF) and colocalized ( Figure 3D ; direct IF; colocalization is indicated by bright yellow) among all of the RA pectinate myocyte types examined from the indicated RA regions. Similar results were obtained from RA sections prepared from a total of 4 hearts.
Additional IF measurements (data not shown) indicated that eNOS and ECSOD expression was high and uniform in ferret SAN sections. These results indicate that at the tissue level, eNOS and ECSOD expression patterns vary not only among the major anatomic regions of the ferret heart (SAN/ atrium versus ventricle) but also within specific anatomic regions of the ventricle (RV/LV epi versus LV endo/septum). 
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nNOS, iNOS, MnSOD, and CuZnSOD: Ventricular Tissue Sections
Having demonstrated heterogeneous expression and colocalization of eNOS and ECSOD in the ventricle, we next sought to determine whether there was basal expression of nNOS, iNOS, MnSOD, and CuZnSOD isoforms in the ventricle and whether the basal expression patterns of these other isoforms were uniform or heterogeneous. Representative results on basal expression patterns of these specific isoforms in ferret ventricular sagittal tissue sections are shown in Figure 3E through 3J (for comparative purposes, the relative intensity profiles [see Materials and Methods] of each isoform across the same transverse midventricular region are also shown in Figure 3E1 through 3J1). With regard to NOS isoforms, 2 interesting findings were as follows: (1) consistent with the immunoblot results (Figure 1 ), low basal expression patterns of both nNOS 39 and iNOS 47 could be detected at the intact ventricular tissue level ( Figure 3F and 3G), and (2) the overall expression patterns for both nNOS and (basal) iNOS were markedly different from that of eNOS (compare Figure 3E with 3F and 3G). In particular, nNOS expression was an approximate inverse of eNOS expression, being relatively high in LV endo and septum and low to absent in LV epi and RV. With regard to SOD isoforms, both MnSOD and CuZnSOD could also be detected ( Figure 3I and 3J) . However, in contrast to ECSOD, the expression of these 2 isoforms was relatively more uniform across all ventricular regions (compare Figure 3H with 3I and 3J; see also Discussion). In summary, similar expression patterns for nNOS, iNOS, MnSOD, and CuZnSOD were observed in ventricular sagittal sections prepared from totals of 5 hearts (nNOS), 4 hearts (iNOS), and 6 hearts (MnSOD and CuZnSOD).
Human Heart: eNOS and ECSOD Expression Patterns in LV Epi and LV Endo Tissue Sections
To test for the possibility that heterogeneous expression of eNOS and ECSOD may be a unique characteristic of ferret heart, we also conducted a limited IF analysis of eNOS and ECSOD expression in LV epi and LV endo tissue samples obtained from human hearts (see Materials and Methods). 
Ferret Heart: Isolated Myocyte Analysis
Having determined overall NOS and SOD isoform expression levels in ferret cardiac tissues, we next conducted indirect IF measurements on samples of myocytes 41, 42 enzymatically isolated from ferret SAN, RA (entire free wall), RV (entire free wall), and LV epi and LV endo regions. Selected positive IF results for NOS and SOD isoform expression in the 4 working myocyte types are shown in Figure 5A through 5D, whereas summarized mean results on approximate percentage myocyte expression of NOS and SOD isoforms in all 5 myocyte types are given in Figure 5E and 5F. With regard to NOS isoforms ( Figure 5E ), eNOS was the predominantly expressed isoform and was observed in the majority of SAN and RA myocytes; however, among ventricular myocytes, eNOS expression was highest in LV epi myocytes (89.1Ϯ0.1%), intermediate in RV myocytes (53.3Ϯ0.5%), and markedly reduced in LV endo myocytes (29.9Ϯ0.5%). A detectable nNOS 39 and basal iNOS expression 47 was also observed in a small subpopulation of each myocyte type, with expression of both being highest in LV endo myocytes (Ϸ20%) and lower to essentially absent in the other myocyte types. In addition, exposure of all 5 isolated myocyte types to selected cytokines (tumor necrosis factor-␣ and interferon-␥; 1-to 4-hour incubations in short-term culture, 37°C) led to a significant increase in iNOS expression, further corroborating both specific iNOS expression and antibody specificity (data not shown).
With regard to SOD isoforms ( Figure 5F ), ECSOD was expressed in the majority of SAN and RA myocytes, but displayed a marked heterogeneous expression pattern among ventricular myocytes, being highest in LV epi myocytes (85.7Ϯ0.9%), intermediate in RV myocytes (57.0Ϯ0.8%), and lowest in LV endo myocytes (45.1Ϯ1.9%). In contrast, MnSOD was nearly uniformly expressed in the majority of all 5 myocyte types. CuZnSOD was also nearly uniformly expressed in all myocyte types except for RV myocytes, in which it was reduced. In summary, at the level of isolated LV epi and LV endo myocytes, eNOS and ECSOD expression paralleled each other. These results indicate that heterogeneous eNOS and ECSOD expression patterns in LV epi versus LV endo myocytes are contributing to the net expression gradients observed in the intact LV wall. These same general conclusions also apply to our results on nNOS and basal iNOS expression.
Ferret Heart: Subcellular Localization of eNOS and SOD Isoforms
To determine the subcellular localization patterns of SOD isoforms within ventricular myocytes, we used EM. Figure  6A1 through 6A4 shows EM results on the localization patterns of SOD isoforms in 60 nm thick sections obtained from ferret LV epi ( Figure 6A1 through 6A3) and LV endo ( Figure 6A4 ) tissue. In LV epi myocytes, MnSOD specifically localized to the mitochondria ( Figure 6A1 ), CuZnSOD was uniformly distributed throughout the myoplasm but was excluded from the mitochondria and sarcolemma ( Figure  6A2 ), and ECSOD was highly expressed and specifically localized to the sarcolemma ( Figure 6A3 ). In LV endo myocytes ( Figure 6A4 ), a similar SOD isoform expression pattern was also observed; however, although ECSOD was again specifically localized to the sarcolemma, its density was markedly reduced compared with that of LV epi myocytes . A1 and A2, Section orientation: whole heart (A1; line indicates transverse cut orientation) and whole heart transversely bisected (A2) showing specific LV epi and LV endo regions (white boxes indicate ϫ60 enlargements) from which sections were prepared. B through E, eNOS and ECSOD expression in LV epi and LV endo sections (7 m thick) from areas indicated in panel A2. Calibration bar: Bϭ10 m. F through J, Comparative results on eNOS and ECSOD expression in a cross section of the whole ferret heart. F1, Orientation: schematic representation of ferret heart. Cut orientation is indicated by white line. F2, Positive control: whole cross section of ferret heart tested with anti-troponin (TnIc) antibody. Note the uniformity of fluorescence in all regions. White boxes (ϫ60 enlargements) indicate the regions where the cross sections shown in panels G through J were taken. G through J, eNOS and ECSOD expression in ferret LV epi and LV endo cross-sectional tissue sections. Fluorescence patterns were obtained from indicated white boxes shown in panel F2. (compare Figure 6A3 and 6A4) . Similar SOD isoform expression patterns were consistently observed in LV epi and LV endo sections prepared from 3 ferret hearts.
EM localization of NOS isoforms was hampered because the NOS antibodies used failed to significantly bind protein A gold. However, because ECSOD is specifically localized to the sarcolemma, ECSOD fluorescence patterns can serve as a specific sarcolemmal marker. Therefore, to determine localization of eNOS, we conducted confocal microscopic analysis 42 on ferret isolated myocytes that had been double labeled (direct IF) for both eNOS and ECSOD. Representative results obtained from RV, LV epi, and LV endo myocytes are shown in Figure 6B through 6D. When a series of optical Z sections (0.75 m thickness) were made progressively through the width of all myocyte types analyzed, the fluorescence intensity patterns were localized to the outer sarcolemmal regions. These results indicate that eNOS is specifically localized to the sarcolemma. It should also be noted that the eNOS and ECSOD fluorescence intensities were relatively more prominent in the RV and LV epi myocytes ( Figure 6B and 6D) compared with the LV endo myocytes ( Figure 6C ).
In summary, these EM and confocal Z-section results demonstrate that eNOS and ECSOD are localized to the sarcolemma of ventricular myocytes and directly confirm the heterogeneous eNOS/ECSOD expression gradients in LV epi versus LV endo myocytes.
Discussion Novel Results: Heterogeneous NOS and SOD Isoform Expression in Heart
It is now recognized that ion channel expression in the heart can be quite heterogeneous. 41, 42 Hence, enzyme systems involved in modulation of cardiac myocyte ion channel function will also probably not be uniformly expressed in the heart, a concept generally ignored in considerations of cardiac function. Our results are therefore important in that they are the first demonstration of distinct heterogeneous basal expression gradients and subcellular localization patterns of NOS and SOD isoforms in the heart. These novel results may provide new insights into mechanisms governing NO-related modulation of cardiac myocyte protein function and may have direct relevance to present controversies regarding NO-related effects on cardiac myocyte ion channels.
eNOS and ECSOD: General Implications
Possibly our most significant finding is the expression gradient and colocalization of eNOS and ECSOD isoforms across the LV wall of both the ferret and human heart (Figure 4) . The fact that heterogeneous eNOS/ECSOD expression exists in both ferret and human heart underscores the general significance of this finding. Our results on ferret isolated myocytes further demonstrate that eNOS and ECSOD expression is markedly heterogeneous among LV epi versus LV endo myocytes and is specifically localized to the sarcolemma of ventricular myocytes (although our present data do not allow us to conclude that eNOS and ECSOD are tightly colocalized to the same specific sarcolemmal microdomains, eg, caveolae). 32 These findings strongly imply a functional correlation between the activities of endogenous myocyte eNOS and ECSOD in the regulation of extracellular and/or sarcolemmal NO⅐/O 2 Ϫ interactions. 7, 19, 27 Ϫ (direct cGMP-independent stimulation). 7 Our present results therefore provide a molecular basis for the dual-mechanism NO-related regulatory model proposed in this previous patchclamp study 7 and the underlying assumptions made therein regarding mechanisms governing sarcolemmal NO⅐/O 2 Ϫ interactions (see Figure 10 in Reference 7; see also Reference 27) . Extrapolating from these previous results, 7 our present IF results could imply the following: (1) that LV epi myocytes may be more influenced by endogenous myocyte eNOS and ECSOD activity, whereas LV endo myocytes may be more influenced by NO-related species generated by remote (nonmyocyte) cell sources (eg, References 48 and 49) and (2) that indirect (inhibitory) effects on I Ca, L may be more dominant in LV epi myocytes, whereas direct (stimulatory) effects on I Ca, L may be more prevalent in LV endo myocytes. 7 In contrast to LV, the intermediate expression of eNOS and ECSOD in ferret RV myocytes suggests that there may be approximately equal NO-related indirect versus direct responses on I Ca, L among the RV myocyte population. It is therefore interesting to note that in our previous study, 7 we observed that the compound SIN-1 (which generates both NO⅐ and OONO Ϫ ) stimulated I Ca, L in approximately half of the RV myocytes studied and inhibited I Ca, L in the other half. These SIN-1 results may now be viewed as being consistent with the intermediate expression pattern of ECSOD in RV myocytes and the predictions of the proposed dualmechanism redox-regulatory model. 7 Heterogeneous ECSOD expression may also provide a basis for the multiple effects that SIN-1 exerts on I Ca, L in other cardiac myocyte preparations (eg, References 5 and 50).
Heterogeneous eNOS and ECSOD expression may also provide a molecular basis for some of the conflicting results reported on the involvement of myocyte NOS activity in modulation of I Ca, L . Two examples would include the following: (1) apparent differences among cardiac myocyte types in mech-anisms governing amplitude and frequency-dependent characteristics of basal I Ca, L 7,11,51 and (2) controversy over the obligatory involvement of endogenous myocyte NO production in cholinergic-mediated inhibition of I Ca, L and other ion channels. 8 -16,52,53 Our results would suggest that generalities about obligatory involvement of NO production in cholinergically mediated modulation of I Ca, L may not be applicable to all cardiac myocyte types. 1,11,8 -16,52,53 We would therefore suggest in future studies of cholinergic modulation (as well as other neuromodulatory compounds) that very careful attention be paid to the exact anatomic tissue region from which myocytes are isolated (particularly ventricular epicardium versus endocardium).
I Kr and I to Rapidly inactivating (I Kr ) and transient outward (I to ) K ϩ currents are important contributors to repolarization in many cardiac myocyte types. 54 Heterogeneous expression patterns of potassium channel ␣ subunits (ERG, Kv1.4, Kv4.2, and Kv4.3) that correlate with I Kr and the 2 major I to phenotypes in ferret LV epi and LV endo myocytes have recently been demonstrated. 41, 42 Interestingly, both ERG 41 and Kv4.2 42 localization in ferret heart closely parallel eNOS and ECSOD expression, whereas Kv1.4 is almost exclusively expressed in ferret LV endo (ie, where eNOS and ECSOD expression is minimal). The latter observation is particularly intriguing, because inactivation of heterologously expressed Kv1.4 is redox-sensitive. 55 These potassium channels may therefore provide a selective system for regional NO-related modulation of cardiac function potentially more complex than that suggested for I Ca, L . 7
iNOS and nNOS
Whereas eNOS was found to be the predominantly expressed isoform, our isolated myocyte results clearly indicated that both nNOS and iNOS are basally expressed in some ferret cardiac myocyte types. The specificity of our iNOS measurements was corroborated by the observation that iNOS expression in ferret myocytes could be upregulated on exposure to cytokines (data not shown). Our finding of nNOS expression is also in general agreement with the recent finding of nNOS expression in the sarcoplasmic reticulum of rabbit and human myocardium. 39 Intriguingly, the basal expression of nNOS and iNOS in the ferret ventricle (Figures 3 and 5) is an approximate inverse of that of eNOS. While the functional consequences of this are presently unclear, if nNOS and iNOS are localized intracellularly, then their relative predominance in LV endo myocytes may provide one mechanism for partially countering the hypothesized predominance of direct NO-related effects in this myocyte type.
MnSOD and CuZnSOD
Consistent with its mitochondrial localization, MnSOD was relatively uniformly expressed in both ventricular sagittal sections and the majority of all enzymatically isolated myocyte types analyzed. Interestingly, myoplasmic CuZnSOD was also relatively uniformly expressed in all myocyte types except for RV myocytes, where it was reduced ( Figure 5F ). There thus appears to be a slight discrepancy between CuZnSOD expression at the whole ventricular tissue level ( Figure 3J ) versus that observed in isolated myocytes. This was the only exception to our general finding that SOD (and NOS) isoform expression in isolated myocytes paralleled that observed in whole tissue sections. Although the underlying reasons for this discrepancy are presently unclear, it may indicate additional contributions of CuZnSOD expression in other nonmyocyte cell types in the ventricular sections (see Materials and Methods: Interpretive Limitations).
Potential Pathological Implications
In conclusion, our results also have some potentially important implications for pathological conditions. For example, our results suggest that iNOS-related pathology 1,2 may be initially more prevalent in LV endo myocytes. Possibly even more intriguing is the fact that many of the injurious effects produced after cardiac ischemic episodes are caused by increased O 2 Ϫ production. 22, 56 Because of lower levels of ECSOD, LV endo myocytes may be much more prone to the injurious effects of excessive O 2 Ϫ generation. The higher expression levels of nNOS and iNOS in LV endo myocytes may also exacerbate excessive OONO Ϫ -mediated effects. In this regard, it may be noted that nitrotyrosine formation (an indirect indicator of OONO Ϫ generation) occurs around foamy macrophages in human atherosclerotic lesions and in myocytes obtained from hearts of patients with myocarditis or sepsis. 22, 57 It will therefore be interesting to determine whether nitrotyrosine formation is most prominent in LV endo myocytes and whether eNOS/ECSOD expression patterns are altered in LV epi versus LV endo tissues during or after various pathological conditions.
